Abstract:Background: At present, the commercial artificial small diameter (< 6 mm) vascular grafts are still unsatisfactory, due to poor biocompatibility and low long-term patency rate. Objective: This study was to design a novel tissue engineering blood vessel constructed by dog bone marrow derived endothelial progenitor cells and decellularized allogeneic vascular scaffolds. Design, time and setting: From December 2005 to December 2007, the experiment, a randomized control trial of cells an histopathology in vitro, was completed in the Affiliated Drum Tower Hospital of Nanjing University Medical School. Materials: The decellularized canine common carotids were obtained by a detergent-enzymatic procedure; Bone marrow mononuclear cells from mongrel adult dogs were isolated using density gradient centrifugation method and cultured in culture flasks coated with fibronectin. Subsequently, the expanded endothelial progenitor cells were seeded on the decellularized scaffolds, and then co-cultured in the self-made bioreactor to construct the tissue engineering blood vessels. Methods: Bilateral common carotid artery and lateral femoral artery in twenty dogs were all exposed. Three vascular segments from each dog were harvested and then randomly divided into three groups according to the transplant with the tissue engineering blood vessels, decellularized allogeneic vascular scaffolds or autogenous vein. Twenty vessels were implanted into the dogs of each group. Main outcome measures: Immunocytochemical staining was used to identify the cultured endothelial progenitor cells; After 6 months of transplantation, the grafts were retrieved for digital subtraction angiography, pathological test and scanning electron microscope examination. Results: Dog bone marrow mononuclear cells presented a cobblestone-like appearance at 10 days of the culture. The immunocytochemistry results were consistent with the phenotype of endothelial progenitor cells; After highly proliferative endothelial progenitor cells were seeded onto the decellularized scaffold for 10 days, seed cells attached well in the lumen of blood vessels; Six months after implantation, the tissue engineering blood vessels were 85% patent and autogenous vein grafts were 90 patent, which was superior to decellularized allogeneic vascular scaffolds (25%). Conclusion: This study provides a new strategy to develop a tissue engineering blood vessel with excellent biocompatibility and high patency rate by the co-culture of dog bone marrow derived endothelial progenitor cells with decellularized vascular scaffolds.

Vessel grafts for tissue engineering revisited—Vessel segments show location‐specific vascularization patterns in ex vivo ring assay

Bioinspired, Artificial, Small-Diameter Vascular Grafts with Selective and Rapid Endothelialization Based on an Amniotic Membrane-Derived Hydrogel.

Improving the hemocompatibility of a porohyperelastic layered vascular graft using luminal reversal microflows

Developing small-diameter vascular grafts with human amniotic membrane: long-term evaluation of transplantation outcomes in a small animal model

Abstract P1126: Development Of A Tissue Engineered Small Vascular Graft With Human Amnion Membrane

Tissue Engineering of Small-Diameter Vascular Grafts by Endothelial Progenitor Cells Seeding Heparin-Coated Decellularized Scaffolds.

Tissue-engineered blood vessels constructed by bone marrow-derived endothelial progenitor cells and decellularized vascular scafflolds

Tissue Engineering of Blood Vessel.

An exploratory study on the preparation and evaluation of a "same-day" adipose stem cell-based tissue-engineered vascular graft

Fabrication of small-diameter in situ tissue engineered vascular grafts with core/shell fibrous structure and a one-year evaluation via rat abdominal vessel replacement model

Tissue engineering of blood vessel: Tissue Engineering Review Series

A self-renewing, tissue-engineered vascular graft for arterial reconstruction

The Development of Construction of Small-Diameter Vascular Grafts in Vivo

Development and validation of small-diameter vascular tissue from a decellularized scaffold coated with heparin and vascular endothelial growth factor.

Tissue-engineering of vascular grafts containing endothelium and smooth-muscle using triple-coaxial cell printing

Circumferentially aligned fibers guided functional neoartery regeneration in vivo

Fabric-Enhanced Vascular Graft with Hierarchical Structure for Promoting the Regeneration of Vascular Tissue

VEGF Combined with DAPT Promotes Tissue Regeneration and Remodeling in Vascular Grafts.

Generation and Grafting of Tissue-Engineered Vessels in a Mouse Model.

Development of A New Pre-Vascularized Tissue-Engineered Construct Using Pre-Differentiated Radscs, Arteriovenous Vascular Bundle and Porous Nano-Hydroxyapatide-Polyamide 66 Scaffold

Development of a Decellularized Human Amniotic Membrane-Based Electrospun Vascular Graft Capable of Rapid Remodeling for Small-Diameter Vascular Applications.